Breast cancer is a clinically heterogeneous and highly complex disease composed of different biological subtypes such as the human epidermal growth factor receptor 2 (HER2), luminal A, luminal B, claudin-low, and basal-like [2]. This evidence concerns the gene ERBB2 and breast cancer.